These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 32687224)
1. MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways. Pérez-Soriano A; Bravo P; Soto M; Infante J; Fernández M; Valldeoriola F; Muñoz E; Compta Y; Tolosa E; Garrido A; Ezquerra M; Fernández-Santiago R; Martí MJ; Mov Disord; 2020 Oct; 35(10):1873-1879. PubMed ID: 32687224 [TBL] [Abstract][Full Text] [Related]
2. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease. Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy. Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283 [TBL] [Abstract][Full Text] [Related]
4. Serum miR-30c-5p is a potential biomarker for multiple system atrophy. Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945 [TBL] [Abstract][Full Text] [Related]
5. Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy. Kim T; Valera E; Desplats P Mol Neurobiol; 2019 Oct; 56(10):7003-7021. PubMed ID: 30968343 [TBL] [Abstract][Full Text] [Related]
6. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes. Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454 [TBL] [Abstract][Full Text] [Related]
7. Serum microRNA expression profiling in patients with multiple system atrophy. Kume K; Iwama H; Deguchi K; Ikeda K; Takata T; Kokudo Y; Kamada M; Fujikawa K; Hirose K; Masugata H; Touge T; Masaki T Mol Med Rep; 2018 Jan; 17(1):852-860. PubMed ID: 29115515 [TBL] [Abstract][Full Text] [Related]
8. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy. Vallelunga A; Ragusa M; Di Mauro S; Iannitti T; Pilleri M; Biundo R; Weis L; Di Pietro C; De Iuliis A; Nicoletti A; Zappia M; Purrello M; Antonini A Front Cell Neurosci; 2014; 8():156. PubMed ID: 24959119 [TBL] [Abstract][Full Text] [Related]
9. Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α-Synucleinopathies. Heras-Garvin A; Danninger C; Eschlböck S; Holton JL; Wenning GK; Stefanova N Mov Disord; 2020 Dec; 35(12):2333-2338. PubMed ID: 32881058 [TBL] [Abstract][Full Text] [Related]
10. White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy. Bettencourt C; Foti SC; Miki Y; Botia J; Chatterjee A; Warner TT; Revesz T; Lashley T; Balazs R; Viré E; Holton JL Acta Neuropathol; 2020 Jan; 139(1):135-156. PubMed ID: 31535203 [TBL] [Abstract][Full Text] [Related]
11. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. Ubhi K; Rockenstein E; Kragh C; Inglis C; Spencer B; Michael S; Mante M; Adame A; Galasko D; Masliah E Eur J Neurosci; 2014 Mar; 39(6):1026-1041. PubMed ID: 24304186 [TBL] [Abstract][Full Text] [Related]
12. Transcriptomic differences in MSA clinical variants. Pérez-Soriano A; Arnal Segura M; Botta-Orfila T; Giraldo D; Fernández M; Compta Y; Fernández-Santiago R; Ezquerra M; Tartaglia GG; Martí MJ; Sci Rep; 2020 Jun; 10(1):10310. PubMed ID: 32587362 [TBL] [Abstract][Full Text] [Related]
16. Analysis and meta-analysis of five polymorphisms of the LINGO1 and LINGO2 genes in Parkinson's disease and multiple system atrophy in a Chinese population. Chen Y; Cao B; Yang J; Wei Q; Ou RW; Zhao B; Song W; Guo X; Shang H J Neurol; 2015 Nov; 262(11):2478-83. PubMed ID: 26254004 [TBL] [Abstract][Full Text] [Related]
17. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922 [TBL] [Abstract][Full Text] [Related]
18. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models. Vidal-Martinez G; Segura-Ulate I; Yang B; Diaz-Pacheco V; Barragan JA; De-Leon Esquivel J; Chaparro SA; Vargas-Medrano J; Perez RG Exp Neurol; 2020 Mar; 325():113120. PubMed ID: 31751571 [TBL] [Abstract][Full Text] [Related]
20. No association of GPNMB rs156429 polymorphism with Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population. Xu Y; Chen Y; Ou R; Wei QQ; Cao B; Chen K; Shang HF Neurosci Lett; 2016 May; 622():113-7. PubMed ID: 27132081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]